Researchers also found that cannabinoids are most effective when used after an initial round of chemotherapy, significantly improving overall results against blood cancer cells.
They also discovered that combining cannabinoids with existing chemotherapy treatments has a better result than with just chemotherapy alone, meaning that a similar level of effect could be achieved through using a lower dose of the chemotherapy.
St. George’s claim that if this were translated to humans, “this lower dose of chemotherapy would mean that the side-effects of chemotherapy could be lessened.”
Dr. Wai Liu said: “We have shown for the first time that the order in which cannabinoids and chemotherapy are used is crucial in determining the overall effectiveness of this treatment.”
Smoking cannabis, however, will not have a similar effect: “These extracts are highly concentrated and purified, so smoking marijuana will not have a similar effect.
“…cannabinoids are a very exciting prospect in oncology, and studies such as ours serve to establish the best ways that they should be used to maximize a therapeutic effect.”
Cannabinoids are the active chemicals in cannabis, known more specifically as phytocannabinoids. When extracted from the plant and purified, they have been shown to possess anticancer properties, especially in certain cancers of the brain.
What could this mean for British medicine? Going off the study’s conclusions, it’s hard to imagine a future without cannabinoids being central to our health system. 4,584 people died from Leukemia in the UK in 2015. If we have the potential to save their lives, is it not our duty as a compassionate society to reclassify cannabis away from Schedule 1 status so more research can be done and more people can be save?
Let us know your thoughts on the study’s findings in the comments!